BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7658239)

  • 21. Radioiodine uptake in non-lactating mammary glands: evidence for a causative role of hyperprolactinemia.
    Ronga G; Bruno R; Puxeddu E; Calcinaro F; Montesano T; Travascio L; Colandrea M; Durante C; Maranghi M; Filetti S; Russo D
    Thyroid; 2007 Apr; 17(4):363-6. PubMed ID: 17465868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stunning effect.
    Gerard SK; Park HM
    J Nucl Med; 2007 Feb; 48(2):328-9; author reply 329-30. PubMed ID: 17268034
    [No Abstract]   [Full Text] [Related]  

  • 23. Experience in the management of thyroid carcinoma by I-131. A report of 39 cases.
    Bricout P; Kibler RS
    J Can Assoc Radiol; 1973 Dec; 24(4):323-7. PubMed ID: 4773908
    [No Abstract]   [Full Text] [Related]  

  • 24. Mediastinal uptake of 131-I in patients with thyroid cancer: may it be referred to normal thymus?
    Bestagno M; Pagliaini R; Maira G; Pizzocaro C
    Eur J Nucl Med; 1993 Jul; 20(7):648. PubMed ID: 8267738
    [No Abstract]   [Full Text] [Related]  

  • 25. [Principles of radionuclide methods of diagnosing and treating primary thyroid cancer and its metastases].
    Purizhanskiĭ II; Lushina LI; Lyzhina VD; Lisenkov PI
    Med Radiol (Mosk); 1982 Oct; 27(10):61-6. PubMed ID: 7176859
    [No Abstract]   [Full Text] [Related]  

  • 26. Scintigraphic control of radioiodine 131-I distribution following administration of therapeutic dose for a differentiated cancer of the thyroid gland.
    Röhling S; Nĕmec J; Zamrazil V; Pohunková D; Jezek V
    Czech Med; 1983; 6(2):125-6. PubMed ID: 6409563
    [No Abstract]   [Full Text] [Related]  

  • 27. [Parotid gland function following radioiodine therapy of thyroid cancer based on data from radionuclide sialoscintigraphy].
    Sorokin IN; Prikhod'ko AG
    Stomatologiia (Mosk); 1987; 66(2):50-2. PubMed ID: 3033850
    [No Abstract]   [Full Text] [Related]  

  • 28. Thyroxine withdrawal in thyroid cancer.
    Sfakianakis GN; Skillman TG; George JM
    Ohio State Med J; 1975 Feb; 71(2):79-82. PubMed ID: 1128859
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases.
    Leung SF; Law MW; Ho SK
    Br J Radiol; 1992 Oct; 65(778):905-9. PubMed ID: 1422665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of the nuclear medicine in the treatment of thyroid carcinoma].
    Börner W; Reiners C
    Med Klin; 1980 Jan; 75(2):80-7. PubMed ID: 7374606
    [No Abstract]   [Full Text] [Related]  

  • 31. Thyroid carcinoma metastatic to pituitary.
    Sziklas JJ; Mathews J; Spencer RP; Rosenberg RJ; Ergin MT; Bower BF
    J Nucl Med; 1985 Sep; 26(9):1097. PubMed ID: 4032051
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effective I-131 therapy in metastasis of thyroid cancer to the cervical vertebrae; a case report].
    Fujiwara K; Endo K; Iwasaki Y; Hosono M; Konishi J; Torizuka K; Seki M
    Rinsho Hoshasen; 1986 Sep; 31(9):1045-8. PubMed ID: 3784042
    [No Abstract]   [Full Text] [Related]  

  • 33. [Iodine scintigraphy of differentiated thyroid carcinoma].
    Nakata K; Tsukamoto E; Ito K; Kato C; Furudate M
    Rinsho Hoshasen; 1988 May; 33(5):589-90. PubMed ID: 3047462
    [No Abstract]   [Full Text] [Related]  

  • 34. Proceedings: Value of scanning in diagnosis and treatment of thyroid cancer.
    Henk JM
    Proc R Soc Med; 1974 Nov; 67(11):1104-5. PubMed ID: 4438290
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thyroid carcinoma and pregnancy].
    da Rosa JC; de Lima GR; Coradazzi ME; Shnaider J
    Rev Paul Med; 1973 Jul; 82(1):1-6. PubMed ID: 4804030
    [No Abstract]   [Full Text] [Related]  

  • 36. Iodine-131 uptake in inflammatory lung disease: a potential pitfall in treatment of thyroid carcinoma.
    Höschl R; Choy DH; Gandevia B
    J Nucl Med; 1988 May; 29(5):701-6. PubMed ID: 3373306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iodine-131 whole-body scan for post-surgical follow-up of differentiated thyroid carcinoma.
    Degrossi OJ; García del Río H; Degrossi EB
    J Nucl Med; 1991 Sep; 32(9):1826. PubMed ID: 1880588
    [No Abstract]   [Full Text] [Related]  

  • 38. Thyroid update.
    Lele RD
    J Assoc Physicians India; 1982 Jan; 30(1):31-6. PubMed ID: 6763030
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic risk assessment after iodine-131 exposure: an opportunity and obligation for nuclear medicine.
    Dottorini ME
    J Nucl Med; 1996 Apr; 37(4):612-5. PubMed ID: 8691250
    [No Abstract]   [Full Text] [Related]  

  • 40. Thyroidal radioactive iodide uptake in the lactating rhesus monkey.
    Ozpinar A; Bruss M; Shelton D; Gillespie J
    Lab Anim; 2010 Apr; 44(2):155-8. PubMed ID: 19959568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.